| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033121719 |
| P356 | DOI | 10.1080/13550280701327038 |
| P698 | PubMed publication ID | 17613711 |
| P2093 | author name string | Mahendra Kumar | |
| Adarsh M Kumar | |||
| Louis Gonzalez | |||
| Benny Fernandez | |||
| Irina Borodowsky | |||
| P2860 | cites work | Real-time PCR in virology | Q24514920 |
| A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml | Q24545015 | ||
| A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children | Q24620746 | ||
| Pathogenesis of human immunodeficiency virus infection | Q24634681 | ||
| Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase | Q28291219 | ||
| CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia | Q28303212 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 | ||
| Gene expression profiling in the post-mortem human brain--no cause for dismay. | Q30996882 | ||
| Identification and characterization of an enhancer in the coding region of the genome of human immunodeficiency virus type 1. | Q33649460 | ||
| Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma | Q33678850 | ||
| Chemokine receptors and virus entry in the central nervous system | Q33797103 | ||
| Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy | Q33932746 | ||
| Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay | Q33971820 | ||
| Pathways to neuronal injury and apoptosis in HIV-associated dementia. | Q34223078 | ||
| In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues | Q35878219 | ||
| Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. | Q35880742 | ||
| Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection | Q36297771 | ||
| Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study. | Q36318621 | ||
| Neuropathology of Human Immunodeficiency Virus Infection | Q36476918 | ||
| Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences | Q36637273 | ||
| Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients | Q37400137 | ||
| The latent reservoir for HIV-1 in resting CD4+ T cells: a barrier to cure | Q37446807 | ||
| Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment | Q37492836 | ||
| Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis | Q38266133 | ||
| Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. | Q38311594 | ||
| The role of mRNA and protein stability in gene expression | Q38696474 | ||
| HIV-1-related neurological disease. | Q38920918 | ||
| Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice | Q38953163 | ||
| Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain | Q39310058 | ||
| Pre‐and Postmortem Influences on Brain RNA | Q40487622 | ||
| Neuroglial-specific factors and the regulation of retrovirus transcription | Q40603318 | ||
| Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome | Q40604776 | ||
| Accumulation of unintegrated circular viral DNA in monocytes and growth-arrested T cells following infection with HIV-1. | Q40701543 | ||
| Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy | Q40751379 | ||
| Neuronal loss in the frontal cortex in HIV infection | Q41151569 | ||
| Chemokine receptors: gateways to inflammation and infection | Q41193992 | ||
| Characterisation of messenger RNA extracted post-mortem from the brains of schizophrenic, depressed and control subjects | Q41893032 | ||
| Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method | Q42465505 | ||
| Quantification of human immunodeficiency virus type 1 proviral DNA by the TaqMan real-time PCR assay | Q42789109 | ||
| The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease | Q43639344 | ||
| High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients | Q44019946 | ||
| Distribution of brain HIV load in AIDS. | Q44706094 | ||
| CNS as an HIV-1 reservoir; BBB and drug delivery | Q44823285 | ||
| HIV in the brain: RNA levels and patterns of zidovudine resistance | Q45027990 | ||
| Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients | Q45415194 | ||
| Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples | Q45744551 | ||
| Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain | Q45759163 | ||
| Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group | Q45759166 | ||
| Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection | Q45770654 | ||
| Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group | Q45773831 | ||
| Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. | Q45775929 | ||
| Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma | Q45782351 | ||
| Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia | Q45783177 | ||
| Spectrum of human immunodeficiency virus-associated neocortical damage | Q45871285 | ||
| Brain viral burden in HIV infection. | Q46003548 | ||
| Neocortical damage during HIV infection | Q46301054 | ||
| Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization | Q46960543 | ||
| Early penetration of the blood-brain-barrier by HIV. | Q48125248 | ||
| The AIDS dementia complex: II. Neuropathology | Q48340087 | ||
| Extensive postmortem stability of RNA from rat and human brain | Q48423893 | ||
| Treating AIDS dementia | Q48684058 | ||
| A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis | Q48743313 | ||
| Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. | Q54036208 | ||
| Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir | Q57176775 | ||
| The isolation and in vitro translation of undegraded messenger RNAs from human postmortem brain | Q70932306 | ||
| Neurological complications of HIV infection | Q71264589 | ||
| Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry | Q71467046 | ||
| The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins | Q73142043 | ||
| HIV mediates a productive infection of the brain | Q73145576 | ||
| Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy | Q74770724 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 210-224 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Journal of NeuroVirology | Q6295640 |
| P1476 | title | Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction | |
| P478 | volume | 13 |
| Q92290404 | An Omics Approach to Extracellular Vesicles from HIV-1 Infected Cells |
| Q54209535 | Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells. |
| Q40391119 | Assays for precise quantification of total (including short) and elongated HIV-1 transcripts. |
| Q57793028 | BCL6 Inhibitor-mediated Downregulation of pSAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation |
| Q47666097 | Brain Structural Changes following HIV Infection: Meta-Analysis. |
| Q34720281 | Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient |
| Q38626559 | Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis |
| Q58240326 | Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis |
| Q34083315 | Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers |
| Q34736406 | Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy |
| Q40447357 | Deformed Subcortical Structures Are Related to Past HIV Disease Severity in Youth With Perinatally Acquired HIV Infection. |
| Q89637539 | Differences in Transcriptional Dynamics Between T-cells and Macrophages as Determined by a Three-State Mathematical Model |
| Q92676513 | Different roles of frontal versus striatal atrophy in HIV-associated neurocognitive disorders |
| Q38930864 | Discordance between peripheral and colonic markers of inflammation during suppressive ART |
| Q64076926 | Disruption of latent HIV in vivo during the clearance of actinic keratosis by ingenol mebutate |
| Q37513129 | Distinct Patterns of Tryptophan Maintenance in Tissues during Kynurenine Pathway Activation in Simian Immunodeficiency Virus-Infected Macaques |
| Q34196506 | Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia |
| Q37094265 | Early detection of simian immunodeficiency virus in the central nervous system following oral administration to rhesus macaques |
| Q34252905 | Early microstructural white matter changes in patients with HIV: a diffusion tensor imaging study |
| Q35965672 | Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease |
| Q34141266 | Elevated brain monoamine oxidase activity in SIV- and HIV-associated neurological disease |
| Q57815643 | Exploration of the involvement of LncRNA in HIV-associated encephalitis using bioinformatics |
| Q39031641 | Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection |
| Q41107466 | HIV encephalopathy: glial activation and hippocampal neuronal apoptosis, but limited neural repair. |
| Q59357751 | HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy |
| Q45954015 | HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. |
| Q55309956 | HIV-1 proteins dysregulate motivational processes and dopamine circuitry. |
| Q36009246 | HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment |
| Q45370440 | Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance |
| Q45383832 | Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains |
| Q47600062 | Immune Interventions to Eliminate the HIV Reservoir |
| Q37181324 | Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection |
| Q58557904 | Inflammation Relates to Poorer Complex Motor Performance among Adults Living with HIV on Suppressive Antiretroviral Therapy |
| Q37399037 | Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors. |
| Q92803873 | Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy |
| Q47201399 | Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART. |
| Q59349953 | Low-frequency fluctuation characteristics in rhesus macaques with SIV infection: a resting-state fMRI study |
| Q90705114 | Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy |
| Q34988471 | Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field |
| Q37308125 | Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter |
| Q37698620 | Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system |
| Q48141474 | National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. |
| Q36072424 | Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. |
| Q38879533 | Neuropharmacologic Approaches to Restore the Brain's Microenvironment. |
| Q33781978 | Pathogenesis of HIV in the central nervous system |
| Q38247035 | Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system |
| Q35018065 | Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers |
| Q37041173 | Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling |
| Q99207830 | Recommendations for measuring HIV reservoir size in cure-directed clinical trials |
| Q39427179 | Role of microglia in methamphetamine-induced neurotoxicity |
| Q35125996 | Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications |
| Q35242182 | SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation |
| Q35271996 | Select host restriction factors are associated with HIV persistence during antiretroviral therapy |
| Q33893665 | Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA |
| Q42482128 | Structural gray and white matter changes in patients with HIV. |
| Q28546901 | Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation |
| Q27316403 | TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection |
| Q54982714 | Temporal/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS. |
| Q37187497 | The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence |
| Q34818798 | The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial |
| Q43505499 | The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure. |
| Q53828206 | The role of catecholamines in HIV neuropathogenesis. |
| Q37055454 | Tissue reservoirs of HIV |
| Q42157707 | Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs |
| Q39077816 | Treating HIV Infection in the Central Nervous System |
| Q56893328 | Viral diseases of the central nervous system |
| Q34990422 | fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence |
Search more.